Abiopharma

Kharsansky Alan 🟢 acquired 84.3K shares (1 derivative) of Satellogic Inc. (SATL) Transaction Date: Jun 11, 2026 | Filing ID: 043389

Arch Capital Group Ltd. Announces Early Results of Cash Tender Offers to Purchase up to an Increased Capped Amount of Certain of Its Subsidiaries’ Debt Securities

Director George Jeffrey P. 🟢 acquired 22.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $6.63 Transaction Date: Jun 15, 2026 | Filing ID: 000004

Director Drapkin Kimberlee C 🟢 acquired 22.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $6.63 Transaction Date: Jun 15, 2026 | Filing ID: 000001

Director MCCOLLUM JAMES W 🟢 acquired 22.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $6.63 Transaction Date: Jun 15, 2026 | Filing ID: 000001

Director Akhtar Amer 🟢 acquired 38.3K shares of Thryv Holdings, Inc. (THRY) Transaction Date: Jun 11, 2026 | Filing ID: 000002

Director Thunen Shelley B 🟢 acquired 22.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $6.63 Transaction Date: Jun 15, 2026 | Filing ID: 000001

Director Guerard Frederic 🟢 acquired 22.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $6.63 Transaction Date: Jun 15, 2026 | Filing ID: 000001

Director Scheiner Zachary 🟢 acquired 22.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $6.63 Transaction Date: Jun 15, 2026 | Filing ID: 000005

Director Gutierrez Miguel 🟢 acquired 20.8K shares (1 derivative) of Satellogic Inc. (SATL) Transaction Date: Jun 11, 2026 | Filing ID: 043387

📋 Quang X. Pham (Officer) plans to sell 40K shares of CADRENAL THERAPEUTICS, INC. (at $3.71 each, total $148K) Filed: Jun 15, 2026 | ID: 043385

Director WILSON TROY EDWARD 🟡 adjusted position in 16.2K shares of PUMA BIOTECHNOLOGY, INC. (PBYI) at $7.20 Transaction Date: Jun 11, 2026 | Filing ID: 020709

Director Kennedy Kelly J. 🟢 acquired 20.8K shares (1 derivative) of Satellogic Inc. (SATL) Transaction Date: Jun 11, 2026 | Filing ID: 043384

Watzinger Gerhard 🔴 sold 2.5K shares of CrowdStrike Holdings, Inc. (CRWD) at $685.24 ($1.7M) Transaction Date: Jun 11, 2026 | Filing ID: 000007

Director Stuglik Brian M 🟡 adjusted position in 18.9K shares of PUMA BIOTECHNOLOGY, INC. (PBYI) at $7.20 Transaction Date: Jun 11, 2026 | Filing ID: 020708